ICH adopts M7(R2) guideline on mutagenic impurities to limit carcinogenic risk
Regulatory NewsJoanne S. Eglovitch
Chemistry, Manufacturing and Controls (CMC)GlobalPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/PolicyRegulatory NewsJoanne S. EglovitchChemistry, Manufacturing and Controls (CMC)GlobalPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/Policy